Hunter Perkins Capital Management, LLC Bristol Myers Squibb CO Transaction History
Hunter Perkins Capital Management, LLC
- $431 Million
- Q1 2025
A detailed history of Hunter Perkins Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hunter Perkins Capital Management, LLC holds 78,115 shares of BMY stock, worth $3.65 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
78,115
Previous 178,550
56.25%
Holding current value
$3.65 Million
Previous $10.1 Million
52.83%
% of portfolio
1.11%
Previous 2.12%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,801Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.95 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.42 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.05 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.43 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...